Page last updated: 2024-12-05

beta-phellandrene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Beta-phellandrene is a monoterpene hydrocarbon with a characteristic peppery aroma. It is a natural product found in various essential oils, such as eucalyptus, rosemary, and lemon myrtle. Beta-phellandrene exhibits various biological activities, including antimicrobial, anti-inflammatory, and antioxidant effects. Its synthesis can be achieved through various methods, including extraction from natural sources and chemical synthesis. Researchers study beta-phellandrene due to its potential applications in pharmaceuticals, cosmetics, and food industries. Its antimicrobial properties make it a potential candidate for developing new antibacterial and antifungal agents. Its antioxidant properties suggest potential benefits in preventing oxidative damage and protecting cells from damage caused by free radicals. Furthermore, beta-phellandrene is investigated for its potential in promoting wound healing and reducing inflammation.'

Cross-References

ID SourceID
PubMed CID11142
CHEMBL ID444254
CHEBI ID48741
MeSH IDM0163309

Synonyms (44)

Synonym
.beta.-phellandrene
p-mentha-1(7),2-diene
cyclohexene, 3-methylene-6-(1-methylethyl)-
nsc53044
nsc-53044
phellandrene, beta
555-10-2
2-p-menthadiene
beta-phellandren
3-methylidene-6-(propan-2-yl)cyclohex-1-ene
CHEBI:48741 ,
beta-phellandrene ,
4-isopropyl-1-methylene-2-cyclohexene
3-isopropyl-6-methylene-1-cyclohexene
3-methylene-6-(1-methylethyl)cyclohexene
3-methylidene-6-propan-2-ylcyclohexene
CHEMBL444254
C19818
AKOS016008994
nsc 53044
einecs 209-081-9
2kk225m001 ,
hsdb 4080
unii-2kk225m001
EPITOPE ID:123895
beta-phellandrene [hsdb]
(+/-)-.beta.-phellandrene
.beta.-phellandrene [mi]
DTXSID4052215 ,
3-isopropyl-6-methylenecyclohex-1-ene
3-isopropyl-6-methylene-1-cyclohexene #
3-methylene-6-(1-methylethenyl)-cyclohexane
phellandrene, .beta.
3-methylene-6-(1-methylethyl)-cyclohexene
beta -phellandrene
3-isopropyl-6-methylenecyclohexene
b-phellandrene
Q19606727
MS-22800
CS-0148637
EN300-2528048
HY-N8573
dtxcid201079569
(+/-)-beta-phellandrene

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The result of comet assay showed that β-phellandrene can significantly induce DNA damage at the dosage of 1425 and 2850mg/kg."( The research of genetic toxicity of β-phellandrene.
Cheng, Z; Chu, H; Hao, W; Huang, Y; Jiang, J; Jin, M; Li, Y; Shang, L; Tao, X; Wang, S; Wei, X; Wu, S; Yang, X, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
phellandrene
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1090801Antifungal activity against Colletotrichum fragariae assessed as size of growth inhibitory zone at concentration of 2 mM in volume of 4 ul of acetone measured after 4 days by TLC based direct bioautography assay2007Journal of agricultural and food chemistry, Oct-17, Volume: 55, Issue:21
Chemical composition and antifungal activity of Arnica longifolia, Aster hesperius, and Chrysothamnus nauseosus essential oils.
AID1090799Antifungal activity against Colletotrichum gloeosporioides assessed as size of growth inhibitory zone at concentration of 2 mM in volume of 4 ul of acetone measured after 4 days by TLC based direct bioautography assay2007Journal of agricultural and food chemistry, Oct-17, Volume: 55, Issue:21
Chemical composition and antifungal activity of Arnica longifolia, Aster hesperius, and Chrysothamnus nauseosus essential oils.
AID1090804Antifungal activity against Colletotrichum acutatum assessed as size of growth inhibitory zone at concentration of 2 mM in volume of 4 ul of acetone measured after 4 days by TLC based direct bioautography assay2007Journal of agricultural and food chemistry, Oct-17, Volume: 55, Issue:21
Chemical composition and antifungal activity of Arnica longifolia, Aster hesperius, and Chrysothamnus nauseosus essential oils.
AID360503Antioxidant activity assessed as DPPH radical scavenging activity1995Journal of natural products, Nov, Volume: 58, Issue:11
Santolindiacetylene, a polyacetylene derivative isolated from the essential oil of Santolina canescens.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (53)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (3.77)18.7374
1990's3 (5.66)18.2507
2000's7 (13.21)29.6817
2010's39 (73.58)24.3611
2020's2 (3.77)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.70 (24.57)
Research Supply Index4.01 (2.92)
Research Growth Index5.28 (4.65)
Search Engine Demand Index47.86 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other54 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]